Cancer Immune Responsiveness Committee

 View Only
last person joined: 4 years ago 

The mission of the CIR Committee is to explore and increase the understanding of cancer immune responsiveness by bringing together leaders in the fields of immunology, cell biology, genetics, computational biology, and other relevant areas. The primary focus of the current committee is to further explore the following topics as they relate to the field of IO: germline genetics, transcriptional patterns, therapeutic interventions, host factors, and cell therapies.

Chair

Francesco Marincola, MD
Sonata Therapeutics, CA


Co-Chair

Alessandra Cesano, MD, PhD
ESSA Pharma Inc.

Current Members
8 Members